A large CRDMO moved chemistry and biology workflows onto the Dotmatics ELN and Data Discovery Platform.
Legacy ELN systems could not handle 6,000+ users, and separate chemical and biological workflows complicated compliance and traceability. The organization adopted the Dotmatics ELN & Data Discovery Platform with centralized registration and inventory and integrations with SnapGene, Geneious and GraphPad Prism. The page reports collaboration across 2,000+ global researchers, consistent data capture and compliance, and interest from further groups.
Dotmatics is a scientific informatics software company offering electronic lab notebooks and data platforms for drug discovery and R&D labs.
This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.
Published by Dotmatics on its own site — read the original case study on dotmatics.com ↗
Related use cases
- 01A chemicals and materials company replaced macro-based workflows with Dotmatics Luma to cut analysis turnaround.
- 02Krystal Biotech rolled the Dotmatics ELN and Platform across five R&D groups.
- 03Sygnature Discovery deployed the Dotmatics ELN and Data Discovery Platform with a client portal.
- 04Debiopharm centralized API stock, project and experimental data on a Dotmatics research-data platform.
- 05Charles River rolled out the Dotmatics ELN to about 500 early discovery researchers.
- 06OpenAI's dedicated healthcare vertical page/launch post.